{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:50:56Z","timestamp":1781077856660,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.metabol.2014.10.028","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T05:43:30Z","timestamp":1414647810000},"page":"S33-S39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"S1","title":["Biomarkers of cardiovascular disease risk in women"],"prefix":"10.1016","volume":"64","author":[{"given":"JoAnn E.","family":"Manson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari S.","family":"Bassuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2014.10.028_bb0005","first-page":"e28","article-title":"Heart disease and stroke statistics\u20142014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2014.10.028_bb0010","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/CIR.0b013e31820faaf8","article-title":"Effectiveness-based guidelines for the prevention of cardiovascular disease in women\u20142011 update: a guideline from the American Heart Association","volume":"123","author":"Mosca","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2014.10.028_bb0015","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1161\/CIRCULATIONAHA.105.548206","article-title":"Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50years of age","volume":"113","author":"Lloyd-Jones","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2014.10.028_bb0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1012848","article-title":"Lifetime risks of cardiovascular disease","volume":"366","author":"Berry","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2014.10.028_bb0025","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2014.10.028_bb0030","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final Report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2014.10.028_bb0035","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2014.10.028_bb0040","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1161\/CIRCULATIONAHA.108.816694","article-title":"Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study","volume":"119","author":"Pencina","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2014.10.028_bb0045","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2014.10.028_bb0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nrcardio.2013.216","article-title":"Risk factors: new risk-assessment guidelines\u2014more or less personalized?","volume":"11","author":"Blaha","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.metabol.2014.10.028_bb0055","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.jacc.2014.04.010","article-title":"Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC\/AHA risk assessment guidelines","volume":"63","author":"Amin","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2014.10.028_bb0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jama.297.6.611","article-title":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score","volume":"297","author":"Ridker","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2014.10.028_bb0065","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.108.814251","article-title":"C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men","volume":"118","author":"Ridker","year":"2008","journal-title":"Circulation"},{"issue":"1748\u201356","key":"10.1016\/j.metabol.2014.10.028_bb0070","first-page":"S1","article-title":"Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health Initiative","volume":"125","author":"Cook","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2014.10.028_bb0075","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(13)62388-0","article-title":"Statins: new American guidelines for prevention of cardiovascular disease","volume":"382","author":"Ridker","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2014.10.028_bb0080","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1373\/clinchem.2013.202796","article-title":"Cardiovascular disease risk prediction in women: is there a role for novel biomarkers?","volume":"60","author":"Paynter","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2014.10.028_bb0085","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2188\/jea.JE20120157","article-title":"Classical and novel biomarkers for cardiovascular risk prediction in the United States","volume":"23","author":"Folsom","year":"2013","journal-title":"J Epidemiol"},{"key":"10.1016\/j.metabol.2014.10.028_bb0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2796.2006.01644.x","article-title":"Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B\/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies","volume":"259","author":"Thompson","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2014.10.028_bb0095","first-page":"2499","article-title":"Lipid-related markers and cardiovascular disease prediction","volume":"307","author":"Di Angelantonio","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2014.10.028_bb0100","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2014.10.028_bb0105","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","article-title":"Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies","volume":"375","author":"Thompson","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2014.10.028_bb0110","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1373\/clinchem.2012.188870","article-title":"Clinical utility of lipoprotein-associated phospholipase A2 for cardiovascular disease prediction in a multiethnic cohort of women","volume":"58","author":"Cook","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2014.10.028_bb0115","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1161\/CIRCULATIONAHA.109.884866","article-title":"B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies","volume":"120","author":"Di Angelantonio","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2014.10.028_bb0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1373\/clinchem.2013.202531","article-title":"Biomarkers in ACS and heart failure: should men and women be interpreted differently?","volume":"60","author":"Motiwala","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2014.10.028_bb0125","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1161\/CIRCULATIONAHA.110.005264","article-title":"Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study","volume":"123","author":"Saunders","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2014.10.028_bb0130","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1001\/jama.2010.1708","article-title":"Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults","volume":"304","author":"deFilippi","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2014.10.028_bb0135","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1161\/CIRCULATIONAHA.110.009928","article-title":"Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study","volume":"123","author":"Everett","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2014.10.028_bb0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/eurheartj\/eht406","article-title":"High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort","volume":"35","author":"Zeller","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2014.10.028_bb0145","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/CIRCIMAGING.113.000341","article-title":"Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease? Clinical risk scores are not sufficient to define primary prevention treatment strategies among asymptomatic patients","volume":"7","author":"Blaha","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.metabol.2014.10.028_bb0150","doi-asserted-by":"crossref","first-page":"438","DOI":"10.7326\/0003-4819-156-6-201203200-00006","article-title":"Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study","volume":"156","author":"Kavousi","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2014.10.028_bb0155","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/CIRCIMAGING.113.000470","article-title":"Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease? Clinical risk scores are sufficient to define primary prevention treatment strategies among asymptomatic patients","volume":"7","author":"Andersson","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2014.10.028_bb0160","first-page":"s337","article-title":"Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis","volume":"12","author":"Tufano","year":"2014","journal-title":"Blood Transfus"},{"key":"10.1016\/j.metabol.2014.10.028_bb0165","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1373\/clinchem.2013.202549","article-title":"Sex differences in the metabolic syndrome: implications for cardiovascular health in women","volume":"60","author":"Pradhan","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2014.10.028_bb0170","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2337\/dc10-0879","article-title":"Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006","volume":"34","author":"Mozumdar","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2014.10.028_bb0175","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2337\/dc10-0942","article-title":"Age and sex differences in the clustering of metabolic syndrome factors: association with mortality risk","volume":"33","author":"Kuk","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2014.10.028_bb0180","unstructured":"Bassuk SS, Manson JE. Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes. Ann Epidemiol, in press."}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049514003370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049514003370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:05:25Z","timestamp":1758427525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049514003370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0026049514003370"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2014.10.028","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of cardiovascular disease risk in women","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2014.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}